Statistics
Publications
15
Citations
418
H-Index
12
Active since
1998
Michael Berlin is an author at Arvinas (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1998–2024
15
15
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
Jennifer Cantley, Xiaofen Ye, Emma Rousseau et al. · Nature Communications · 2022 · 129 citations · Full text
Michael Berlin, Jennifer Cantley, Mark Bookbinder et al. · Journal of Medicinal Chemistry · 2024 · 30 citations · Full text
Robert Aslanian, Mwangi wa Mutahi, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 27 citations · Full text
1–5 of 15